SonoScape Medical Corp. (SHE:300633)

Market Cap	11.27B -15.1%
Revenue (ttm)	2.07B +1.2%
Net Income	66.92M -72.4%
EPS	0.15 -72.2%
Shares Out	429.82M
PE Ratio	169.20
Forward PE	42.30
Dividend	0.10 (0.39%)
Ex-Dividend Date	May 29, 2025

Volume	4,348,665
Average Volume	3,120,082
Open	23.75
Previous Close	25.56
Day's Range	23.75 - 26.35
52-Week Range	23.23 - 37.73
Beta	-0.39
RSI	50.65
Earnings Date	Apr 17, 2026

About SonoScape Medical

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. The company offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surge...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 3,122
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300633

Financial Performance

In 2024, SonoScape Medical's revenue was 2.01 billion, a decrease of -5.02% compared to the previous year's 2.12 billion. Earnings were 142.40 million, a decrease of -68.67%.